|
Volumn 29, Issue 12, 2008, Pages 591-593
|
Stem-cell-derived products: an FDA update
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CELL THERAPY;
CLINICAL RESEARCH;
DRUG SAFETY;
EMBRYONIC STEM CELL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SOMATIC CELL;
STEM CELL;
TERATOMA;
UNITED STATES;
|
EID: 56349086509
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/j.tips.2008.09.003 Document Type: Note |
Times cited : (9)
|
References (0)
|